Why the study?
Data concerning the impact of anaemia and iron deficiency on clinical outcomes in patients with cardiogenic shock were scarce.
Does the presence of anaemia or iron deficiency impact clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction?
Population
427 CS patients due to AMI from the CULPRIT-SHOCK trial
Comparison
Neither anaemia nor ID vs anaemia without ID vs anaemia with ID vs ID without anaemia
Design
Substudy of the CULPRIT-SHOCK trial
Follow-up
30 days
Authors
Loading...
Anaemia without ID signals higher risk in AMI-CS; leaves open whether correction improves outcomes.
Does the presence of anaemia or iron deficiency impact clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction?
In patients with cardiogenic shock complicating AMI, anaemia without iron deficiency at presentation is associated with a significantly higher risk of 30-day mortality or need for renal replacement therapy, whereas iron deficiency alone does not impact these outcomes.
Obradović et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: